Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.25%
1,110.47
+13.75
+1.25%
1,096.721,098.741,113.821,098.74
SIXC
Communications
SIXC
Communications
SIXC
-1.19%
604.07
-7.25
-1.19%
611.32611.32611.32603.33
SIXE
Energy
SIXE
Energy
SIXE
+2.56%
1,201.49
+29.95
+2.56%
1,171.541,176.151,202.381,176.15
SIXI
Industrials
SIXI
Industrials
SIXI
+1.01%
1,765.30
+17.67
+1.01%
1,747.631,747.671,770.511,744.43
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
630.42
-1.07
-0.17%
631.49631.23633.90627.95
SIXR
Staples
SIXR
Staples
SIXR
-1.00%
841.45
-8.49
-1.00%
849.94850.23850.23836.20
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.35%
218.83
+0.77
+0.35%
218.06218.06219.96218.02
SIXT
Technology
SIXT
Technology
SIXT
+1.31%
3,582.23
+46.20
+1.31%
3,536.033,549.423,590.523,543.38
SIXU
Utilities
SIXU
Utilities
SIXU
+0.97%
913.89
+8.82
+0.97%
905.07908.07916.83907.68
SIXV
Health care
SIXV
Health care
SIXV
-0.38%
1,444.33
-5.53
-0.38%
1,449.861,451.341,464.451,440.75
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,412.96
-17.51
-0.72%
2,430.472,415.842,422.952,396.14
ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$21.80
-2.68%
(-0.60) 1D
$21.91
+0.50% (+0.11)
After hours
Closed: May 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACAD...
Open
$22.10
High
$22.50
Low
$21.75
Mkt. cap
3.73B
Avg. vol.
1.83M
Volume
33.00
P/E ratio
9.96
52-wk high
$28.34
52-wk low
$16.86
EPS
$2.19
Beta
0.86
Shares outstanding
171.24M
No. of employees
797
News stories
From sources across the web
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com
Last report
May 6, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.02 / $0.10
-78.97%miss
Revenue / Est. (USD)
268.06M / 279.28M
-4.02%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
264.57M
278.63M
283.99M
268.06M
Cost of goods sold
98.68M
109.48M
110.98M
101.66M
Cost of revenue
98.68M
109.48M
110.98M
101.66M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
133.51M
133.40M
155.62M
171.02M
Operating expense
133.51M
133.40M
155.62M
171.02M
Total operating expenses
232.19M
242.88M
266.60M
272.68M
Operating income
32.37M
35.76M
17.39M
-4.62M
Other non operating income
594.00K
593.00K
596.00K
542.00K
EBT including unusual items
40.21M
44.60M
26.32M
3.98M
EBT excluding unusual items
40.21M
44.60M
26.32M
3.98M
Income tax expense
13.54M
-27.18M
-247.25M
344.00K
Effective tax rate
33.68%
-60.96%
-939.43%
8.64%
Other operating expenses
-
-
-
-
Net income
26.67M
71.78M
273.57M
3.64M
Net profit margin
10.08%
25.76%
96.33%
1.36%
Earnings per share
0.16
0.42
0.14
0.02
Interest and investment income
7.24M
8.25M
8.33M
8.06M
Interest expense
-
-
-
-
Net interest expenses
7.24M
8.25M
8.33M
8.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
35.31M
38.71M
20.32M
-1.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more